Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy

Journal of Neuroimmunology

Volumn 135, Issue 1-2, 2003, Pages 148-153

  Schmidt, Stephan ^a   Marrosu, Giovanna Maria ^b   Kölsch, Heike ^a   Haase, Claus G ^c   Ferenczik, Stanislav ^c   Sokolowski, Piotr ^d   Köhler, Wolfgang ^d   Schmidt, Martina ^a   Papassotiropoulos, Andreas ^e   Heun, Reinhard ^a   Grosse Wilde, Hans ^c   Klockgether, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Neurol Dept Sachsisches Krankhs   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adrenoleukodystrophy; Adrenomyeloneuropathy; HLA; Interleukin 6; Myelin oligodendrocyte glycoprotein

Indexed keywords

ANTIBODY; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADRENOLEUKODYSTROPHY; ADULT; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0037310252     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00445-9     Document Type: Article

References (27)

1. Aubourg P., Dubois-Dalcq M. X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia? Glia. 29:2000;186-190.
2. Berger J., Bernheimer H., Fae I., Braun A., Roscher A., Molzer B., Fischer G. Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles. Biochem. Biophys. Res. Commun. 216:1995;447-451.
3. Bodmer J.G., Marsh S.G., Albert E.D.et al. Nomenclature of the factors of the HLA. Eur. J. Immunogenet. 21:1994;485-517.
4. Bowcock A.M., Ray A., Ehrlich H., Sehgal P.B. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acids Res. 17:1989;6855-6864.
5. Ferencik S., Grosse-Wilde H. Caucasian German normal. Terasaki P.I., Gjertson D.W. HLA-1997. 1997;222-223 UCLA Tissue Typing Laboratory, CA, USA.
6. Gomez-Lira M., Marzari M.G., Uziel G., Pignatti P., Rizzuto N., Salviati A. Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy. J. Neuroimmunol. 111:2000;245-247.
7. Haase C.G., Guggenmoos J., Brehm U., Andersson M., Olssom T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and healthy controls. J. Neuroimmunol. 114:2001;220-225.
8. Heun R., Papassotiropoulos A., Jessen F., Maier W., Breitner J.C. A family study of Alzheimer disease and early- and late-onset depression in elderly patients. Arch. Gen. Psychiatry. 58:2001;190-196.
9. Kumar A.J., Köhler W., Kruse B., Naidu S., Bergin A., Edwin A., Moser H.W. MR findings in adult-onset adrenoleukodystrophy. Am. J. Neuroradiol. 16:1995;1227-1237.
10. Linker-Israeli M., Wallace D.J., Prehn J., Michael D., Honda M., Taylor K.D., Paul-Labrador M., Fischel-Ghodsian N., Fraser P.A., Klinenberg J.R. Association of IL-6 gene alleles with systemic lupus erythematodes (SLE) and with elevated IL-6 expression. Genes Immun. 1:1999;45-52.
11. Malfroy L., Viratelle C., Coppin H., Borot N., Roth M.P. Polymorphic tri- and tetranucleotide repeats in exons 1 and 8 of the myelin oligodendrocyte glycoprotein (MOG) gene. Hum. Genet. 96:1995;737-738.
12. McGuiness M.C., Powers J.M., Bias W.B., Schmeckpeper B.J., Segal A.H., Gowda V.C., Wesselingh S.L., Berger J., Griffin D.E., Smith K.D. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 75:1997;174-182.
13. Moser H.W. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 120:1997;1485-1508.
14. Olerup O., Hillert J. HLA class II-associated susceptibility in multiple sclerosis: a critical review. Tissue Antigens. 38:1991;1-15.
15. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39:1992;225-235.
16. Olerup O., Aldener A., Fogdell A. HLA-DQB1 and HLA-DQA1 typing by PCR amplification with sequence specific primers in 2 hours. Tissue Antigens. 41:1993;119-134.
17. Papassotiropoulos A., Bagli M., Jessen F., Bayer A.T., Maier W., Rao M.L., Heun R. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45:1999;666-668.
18. Pham-Dinh D., Della Gaspera B., Kerlero de Rosbo N., Dautigny N. Structure of the human myelin/oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms. Genomics. 29:1995;345-352.
19. Raine C.S., Cannela B., Hauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46:1999;144-160.
20. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122:1999;2047-2056.
21. Roth M., Dolbois L., Borot N., Pontarotti P., Clanet M., Coppin H. Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. J. Neuroimmunol. 61:1995;117-122.
22. Roth M.P., Malfroy L., Offer C., Sevin J., Enault G., Borot N., Pontarotti P., Coppin H. The human myelin oligodendrocyte (MOG) gene: complete nucleotide sequence and structural characterization. Genomics. 28:1995;241-250.
23. Schmidt S., Papassotiropoulos A., Bagli M., Harzheim M., Heun R., Klockgether T. No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′ flanking region of the interleukin-6 gene in patients with multiple sclerosis. Neurosci. Lett. 294:2000;139-142.
24. Schmidt S., Haase C.G., Bezman L., Moser H., Schmidt M., Köhler W., Linington C., Klockgether T. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 119:2001;88-94.
25. Stefferl A., Brehm U., Linington C. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neural Transm., Suppl. 58:2000;123-133.
26. Vandenbroeck K., Fiten P., Ronsse I., Goris A., Porru I., Melis C., Rolesu M., Billiau A., Marrosu M.G., Odenakker G. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes Immun. 1:2000;460-463.
27. Van Geel B.M., Bezman L., Loes D.J., Moser H.W., Raymond G.V. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann. Neurol. 49:2001;186-194.